Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Breast Cancer MetastaticSentinel Lymph NodeSentinel Lymph Node Biopsy (SLNB)Metastasis
Interventions
DIAGNOSTIC_TEST

NIR-II probe (i.e ICG-CK) incubation solution

After incubating the lymph node tissue with an optimal concentration of NIR-II probe for an appropriate amount of time, the tissue is washed with eluent, and then the fluorescence intensity of different tissues is detected to assess whether the tissue has cancer tissue invasion.

Trial Locations (1)

Unknown

RECRUITING

Yunnan Cancer Hospital, Kunming, Yunnan 650118, Kunming

All Listed Sponsors
collaborator

Xiang'an Hospital of Xiamen University

OTHER

lead

Yunnan Cancer Hospital

OTHER